The brain shrinkage observed in Alzheimers may be prevented by semaglutide, the drug in OzempicZEPHYR/Science Photo Library/AlamyOzempic and Wegovy are already transforming how we treat type 2 diabetes and obesity, and from next year another condition affecting millions of people worldwide might be added to the list: Alzheimers disease.Two clinical trials investigating semaglutide, the drug in Ozempic and Wegovy, as a therapy for early Alzheimers are expected to conclude in 2025. If the results are positive, it could mark a breakthrough in treating this intractable condition.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek